Skip to content

Ultrasound guided radiofrequency ablation of fibroids using GYIDE System

Ultrasound Guided Transcervical Radiofrequency Ablation Of Uterine Fibroids With GYIDE System : Safety And Ease Of Use

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052627
Enrollment
10
Registered
2023-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R877- Abnormal histological findings inspecimens from female genital organs

Interventions

Intervention1: Radiofrequency ablation for uterine fibroid using GYIDE: GYIDE: GYIDE is intended for processing diagnostic ultrasound imaging to provide planning and positional guidance for transcervi

Sponsors

Nesa Medtech Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women aged 35 to 60 years subjected to hysterectomy due to fibroid with FIGO types 2, 3, 4, 5 and 2-5("transmural") 2. Women willing to provide informed consent for participation in the study and willing to undergo this RFA for fibroid using (GYIDE)

Exclusion criteria

Exclusion criteria: 1. Presence of a single polyp? 1.5cm or multiple polyps of any size. 2. Presence of more than 4 fibroids and fibroid with diameter > 5.0cm 3. One or more clinically relevant fibroids that are significantly calcified. 4. Any abnormality of the endometrial cavity that obstructs access of the handpiece 5. Total uterine volume > 1000cc

Design outcomes

Primary

MeasureTime frame
Assess the safety issues associated with the usage of GYIDE system.Timepoint: To assess the presence of any adverse events during the 15 days post surgery (Fever,Bleeding, BowelMovement,Vomiting,Nausea ,Bloated,Uncomfortable Urination).

Secondary

MeasureTime frame
1. Assess and record the ease of usage of GYIDE system 2. Screening the hysterectomy specimen for any unintended perforation and determining the ablation zone.Timepoint: 1. To record the ease of using GYIDE system on a scale of 0 to 5 2. To record the region of ablation and no damage to the serosa

Countries

India

Contacts

Public ContactSudhir Patel

Nesa Medtech Private Limited

sreekar@nesamedtech.com9900166988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026